住院期间血清肌酐水平波动与长期终末期肾病及死亡率的关系
这项在以色列一家大型三级医院开展的回顾性队列研究纳入2007年9月1日至2022年7月31日期间收治于内科病房、住院期间未透析、至少完成3次肌酐检测且出院eGFR>60 mL/min/1.73 m2的患者,排除既往慢性肾脏病者,共40 558例。暴露依据住院期间首次与末次eGFR的关系定义。入院时eGFR正常者34 332例(85%),eGFR降低者6226例(15%)。eGFR降低组出院时肾功能看似正常,但1年死亡风险升高18%(AHR 1.18;95%CI 1.11-1.24),10年ESKD风险升高267%(AHR 3.67;95%CI 2.43-5.54),入院eGFR 0-45 mL/min/1.73 m2者风险最高。作者认为,此类患者可能面临增加的长期ESKD和死亡风险。
要点
- 入院eGFR降低、出院eGFR正常的患者1年死亡风险升高18%(AHR 1.18;95%CI 1.11-1.24)。
- 同一人群10年ESKD风险升高267%(AHR 3.67;95%CI 2.43-5.54)。
- 入院eGFR 0-45 mL/min/1.73 m2的患者风险最高。
- 共40 558例,入院eGFR降低者6226例(15%),正常者34 332例(85%)。
- 作者认为,出院时无临床明显残余肾病的患者可能面临增加的长期ESKD和死亡风险。
适用人群与场景
- 2007年9月1日至2022年7月31日在以色列一家大型三级医院内科病房住院的患者。
- 住院期间未接受透析、至少完成3次肌酐检测、出院eGFR>60 mL/min/1.73 m2。
- 排除既往诊断为慢性肾脏病的患者。
诊断标准与关键阈值
- 采用2022年慢性肾脏病流行病学协作组公式由血清肌酐估算肾小球滤过率,eGFR>60 mL/min/1.73 m2视为正常。
- 暴露依据住院期间首次与末次eGFR值的关系定义。
研究设计与关键结果
- 回顾性队列研究,纳入40 558例患者,中位年龄69岁(IQR 56-80),女性18 004例(44%),男性22 554例(56%)。
- 入院时eGFR正常者34 332例(85%),eGFR降低者6226例(15%)。
- 入院eGFR降低组出院时肾功能看似正常,但1年全因死亡风险升高18%(AHR 1.18;95%CI 1.11-1.24)。
- 入院eGFR降低组10年ESKD风险升高267%(AHR 3.67;95%CI 2.43-5.54)。
- 入院eGFR 0-45 mL/min/1.73 m2的患者风险最高。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,入院时肾功能降低而出院时无临床明显残余肾病的患者可能面临增加的长期ESKD和死亡风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Acute kidney injury is associated with poor outcomes, but the clinical implication of reversible serum creatinine level fluctuations during hospitalization not necessarily defined as acute kidney injury is poorly understood.
OBJECTIVE: To investigate the long-term outcomes of patients without previously diagnosed kidney disease who present with decreased kidney function and are subsequently discharged with apparently normal kidney function.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted of patients hospitalized in a large tertiary hospital in Israel between September 1, 2007, and July 31, 2022. The study included patients admitted to an internal medicine ward. Patients had not undergone dialysis during the index hospitalization, had at least 3 creatinine tests performed during hospitalization, and had a discharge estimated glomerular filtration rate (eGFR) exceeding 60 mL/min/1.73 m2. Patients with preexisting chronic kidney disease were excluded.
EXPOSURE: Glomerular filtration rate was estimated from serum creatinine values using the updated 2022 Chronic Kidney Disease Epidemiology Collaboration formula, and eGFR greater than 60 mL/min/1.73 m2 was regarded as normal. Exposure was defined based on the association between the first and last values determined during hospitalization.
MAIN OUTCOMES AND MEASURES: All-cause mortality in the year following the index hospitalization and end-stage kidney disease (ESKD) in the 10 years following the index hospitalization.
RESULTS: A total of 40 558 patients were included. Median age was 69 (IQR, 56-80) years, with 18 004 women (44%) and 22 554 men (56%). A total of 34 332 patients (85%) were admitted with a normal eGFR and 6226 (15%) with decreased eGFR. Patients with decreased eGFR on presentation had an 18% increased mortality in the year following hospitalization (adjusted hazard ratio [AHR], 1.18; 95% CI, 1.11-1.24) and a 267% increased risk of ESKD in the 10 years following hospitalization (AHR, 3.67; 95% CI, 2.43-5.54), despite having been discharged with apparently normal kidney function. The highest risk was noted in patients who presented to the hospital with an eGFR of 0 to 45 mL/min/1.73 m2.
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that patients who present with decreased kidney function and are discharged without clinically evident residual kidney disease may be at increased long-term risk for ESKD and mortality.
参考来源
- Efros O, Beckerman P, Basson AA, et al. Fluctuations in Serum Creatinine Levels During Hospitalization and Long-Term End-Stage Kidney Disease and Mortality. JAMA Netw Open. 2023. PMID: 37535358. doi:10.1001/jamanetworkopen.2023.26996
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。